Tag: "diabetes drug side effects"

Invokana: This New Diabetes Drug Could Be The Worst Yet

| May 5, 2014 | Comments (11)

I’ve said it before – beware of new diabetes drugs. And you should be particularly wary of the latest offering from Big Pharma to hit the UK market. Invokana (canagliflozin) is one of a novel class of drugs called sodium-glucose transport protein 2 (SGLT2) inhibitors, which work by increasing the amount of glucose passed out […]

Read More

Heart Failure Risks Of Diabetes Drugs Are Being Ignored

| April 17, 2014 | Comments (0)

In May last year, I wrote in The Real Diabetes Truth how the vast majority of diabetes research hasn’t properly addressed the cardiovascular risks associated with diabetes drugs. Now, a leading UK heart specialist has blown the whistle on clinical trials that fail to even record the incidence of heart failure, one of the most […]

Read More

Diabetes Drugs Cause Pancreatitis, Heart Failure And Hypoglycaemia

| November 28, 2013 | Comments (0)

At the American College of Rheumatology Annual Meeting in San Diego this October, scientists from the prestigious Brigham and Women’s Hospital in Boston presented research findings that suggested a class of diabetes drugs could cut the risk of autoimmune diseases. Their conclusions were not based on clinical trials but on an analysis of data from […]

Read More

New Diabetes Drugs Could Cause Pancreatitis

| March 28, 2013 | Comments (2)

In the past I have highlighted some of the numerous side effects associated with prescription diabetes drugs. This is especially relevant when it comes to new diabetes drugs. A case in point is a new class of diabetes drugs, called GLP-1 agonists, which has already been linked to the increased risks of pancreatitis and pancreatic […]

Read More

How Drug Companies Harm Diabetes Patients

| October 13, 2012 | Comments (1)

One of my earliest posts on Real Diabetes Truth warned of the dangers associated with anti-diabetes drugs and mentioned Avandia as an example of everything that is bad about the pharmaceutical industry. This diabetes drug, manufactured by Glaxo Smith Kline (GSK) was finally taken off the market in 2010 after studies showed it was linked […]

Read More